Bealartan Plus Tablet

Adult dose

The usual dose for this medication is one tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg per day are not recommended. For patients whose blood pressure is not controlled with monotherapy of losartan or hydrochlorothiazide, treatment should be initiated with Losartan Potassium 50 mg/Hydrochlorothiazide 12.5 mg once a day.

Child dose

There is no experience in using this combination of losartan-hydrochlorothiazide in children and adolescents, so it should not be administered to this population.

This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Women who are pregnant or may become pregnant should not take this medication. Patients with hypersensitivity to this drug or its components, certain kidney and liver disorders, and electrolyte imbalances should not take this medication. Additionally, patients with specific genetic disorders, diabetes, and severe kidney dysfunction are also advised not to use this drug. Patients with very low blood pressure or impaired kidney function, liver dysfunction, hyperuricemia, or gout should use this medication with caution. Since hydrochlorothiazide may cause electrolyte imbalances in the blood, regular blood tests are required. This medication may make the skin sensitive to sunlight, so sunlight exposure should be limited, and if there are any skin changes, a doctor should be consulted immediately. Dizziness or drowsiness may occur during treatment, so caution is necessary when driving or operating machinery. There may be drug interactions, so when taking with potassium supplements or certain blood pressure medications and diuretics, it is important to consult with a physician. Hydration should be monitored during treatment, and if dehydration symptoms occur, medical assistance should be sought immediately. There is insufficient experience regarding the administration to children and adolescents, so it is not used in this population. Elderly patients may experience side effects more frequently, so special care is needed during administration.

Serious side effects

Hives, severe swelling (edema), angioedema (swelling of the lips and eyelids and facial rash), exfoliative dermatitis, hemolysis, angina, arrhythmia (atrial fibrillation, sinus bradycardia, tachycardia, ventricular tachycardia, ventricular fibrillation), cerebrovascular accident, myocardial infarction, secondary atrioventricular block, respiratory distress, acute respiratory distress syndrome (ARDS), jaundice (intrahepatic cholestatic jaundice), mucocutaneous syndrome (Stevens-Johnson syndrome), toxic epidermal necrolysis,

Mild side effects

• Abdominal pain
• swelling
• palpitations
• back pain
• dizziness
• cough
• sinusitis
• upper respiratory infection
• weakness/fatigue
• diarrhea

This medication is sensitive to light and should be stored in a container that protects it from light. Furthermore, it is safe to store the medication at room temperature between 1°C and 30°C. This helps maintain the medication's effectiveness and prevent deterioration.

Appearance

Yellow oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle